Mr. Thomas Saunders
Of Counsel, RISSMAN HENDRICKS & OLIVERIO, LLP
Member of the Law Council
Council Member Biography
Thomas Saunders is an Of Counsel at Rissman Hendricks & Oliverio. He specializes in representing emerging medical technology, biotechnology/genetic engineering and pharmaceutical concerns, particularly as to patent prosecution, patent strategy, IP licensing matters and ANDA Paragraph IV opinions. His practice also includes interference practice, trademark and copyright matters, as well as cyber squatting domain name disputes. Mr. Saunders has a substantial background in biotechnology and chemical patent practice, facilitated by his graduate studies in physiology at Case Western Reserve University and Albany Medical College. He has worked with entrepreneurs in the biomedical field from the earliest steps. He lectures and has authored several publications including Life Sciences Lawyering: Staying Within the MTD, India And China: New Frontiers In Pharma, Secrets of Successful Patent (non) Litigation, Patents as a Cash Crop: Sowing, Growing, Reaping & Litigating. (This is me - Update Profile)
Employment History
- 2009 - Unspecified
- Of Counsel, RISSMAN HENDRICKS & OLIVERIO, LLP
- 2007 - 2009
- Of Counsel, SEYFARTH SHAW LLP
- 2002 - 2007
- Partner, BROWN RUDNICK LLP
- 1990 - 2002
- Partner, Lorusso & Loud
GLG NewsSM Analyses by Thomas Saunders(?)
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
-
RIPENING INHIBITORS: ROSY FUTURE OR BRUISED FRUIT?
December 21, 2007
Current and Potential Commercial Applicationsof the Suppression of Ethylene Action by 1-MCP in Plants | www.rohmhaas.com
Product shelf-life is a major economic concern for the agricultural industry. The biological mechanism for regulating the ripening of fruits is mediated by ethylene. Ethylene management is addressed in three ways: 1) Ethylene absorption 2) Inhibition of ethylene biosynthesis and 3) Prevention of ethylene receptor signaling. In the ripening control patent landscape novel cyclopropene compounds function as ethylene receptor blockers. Of the 60 U.S. patents that have issued, approximately 15 are related to cyclopropenes, while the remaining 45 are more or less evenly distributed between about 20 different ethylene management technologies. AgroFresh Inc., a Rohm and Haas subsidiary, has staked out a significant position in ethylene receptor blocking technology by claiming a wide range of cyclopropene derivatives
-
Defending Knock-Offs: Head-to-head With Brand Names in Trademark, Copyright, and Internet Marketing
March 1, 2007
Defending Knock-Offs: Head-to-head With Brand Names in Trademark, Copyright, and Internet Marketing | www.iptoday.com
-Name Brands vs, Knock-Offs: Strategies and Counter-Strategies
-Vulnerabilities of Name Brand Copyrights
-Why the internet Knock-Off market will always exist
Leading institutions connect with Thomas Saunders through GLG
GLG Study Groups with Thomas Saunders(?)
| Study Group Name | No. Members |
|---|---|
| Experts in the Leisure & Lodging Council | 4887 |
| Experts in the Automotive Council | 3422 |
| Medical Device Experts | 319 |
| Biotechnology Patent Experts: Lawyers (US) | 99 |
| Medical Geneticists (US) | 85 |
GLG Live Meetings with Thomas Saunders(?)
Thomas Saunders has not participated in any GLG Live Meetings.
View all GLG Live Meetings in Legal, Economic & Regulatory Affairs